These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2087492)

  • 21. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinin receptors and memory: a radial maze study.
    Harro J; Oreland L
    Pharmacol Biochem Behav; 1993 Mar; 44(3):509-17. PubMed ID: 8451255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
    Varga G; Scarpignato C
    Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrel rotation induced by vasopressin and related peptides in rats.
    Kruse H; Van Wimersma Greidanus TB; De Wied D
    Pharmacol Biochem Behav; 1977 Oct; 7(4):311-3. PubMed ID: 563083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of a potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice.
    Ohshio G; Saluja A; Leli U; Sengupta A; Steer ML
    Pancreas; 1989; 4(6):739-43. PubMed ID: 2813332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study.
    Hagino Y; Moroji T
    Brain Res; 1994 Apr; 644(1):40-6. PubMed ID: 8032948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of caerulein and CCK antagonists on tolerance induced to morphine antinociception in mice.
    Zarrindast MR; Zabihi A; Rezayat M; Rakhshandeh H; Ghazi-Khansari M; Hosseini R
    Pharmacol Biochem Behav; 1997 Sep; 58(1):173-8. PubMed ID: 9264087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The action of the cholecystokinin-A receptor antagonist, devazepide, on the digestive system of the chicken.
    Furuse M; Choi YH; Satoh S; Okumura J
    Experientia; 1996 Apr; 52(4):353-6. PubMed ID: 8620940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does somatostatin analogue prevent experimental acute pancreatitis?
    Murayama KM; Drew JB; Joehl RJ
    Arch Surg; 1990 Dec; 125(12):1570-2. PubMed ID: 2244811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A behavioral pharmacological study on CCK-8 related peptides in mice.
    Moroji T; Hagino Y
    Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrel rotation evoked by intracerebroventricular injection of somatostatin and arginine-vasopressin is accompanied by the induction of c-fos gene expression in the granular cells of rat cerebellum.
    Kamegai J; Minami S; Sugihara H; Wakabayashi I
    Brain Res Mol Brain Res; 1993 Apr; 18(1-2):115-20. PubMed ID: 8097547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
    J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of neural cholecystokinin-1 receptors induces relaxation of the isolated rat duodenum which is reduced by nitric oxide synthase inhibitors.
    Martins SR; Oliveira RB; Ballejo G
    Braz J Med Biol Res; 2006 Feb; 39(2):271-5. PubMed ID: 16470315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of SMS 201-995 on basal and stimulated pancreatic secretion in rats.
    Guan D; Maouyo D; Sarfati P; Morisset J
    Endocrinology; 1990 Jul; 127(1):298-304. PubMed ID: 2361474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. II. Visual/vestibular interactions and efficacy of antiseizure drugs.
    Wurpel JN; Dundore RL; Barbella YR; Balaban CD; Keil LC; Severs WB
    Brain Res; 1986 Feb; 365(1):30-41. PubMed ID: 3484995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups.
    Smith GP; Tyrka A; Gibbs J
    Pharmacol Biochem Behav; 1991 Jan; 38(1):207-10. PubMed ID: 2017446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.